An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...
Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused ​tumors to disappear or shrink in an early-stage ‌trial.
A 2026 review finds that GSTP1 promoter methylation is a powerful prostate-cancer signal with limited routine clinical use ...
A Turkish clinical study links miR-188-5p and ER stress markers GRP78 and CHOP to prostate cancer aggressiveness, with a ...
AlphaVac, Auryon, NanoKnife growth vs execution risk and margin swings. Click for this updated look at ANGO prospects.
A cancer drug developed by the Chinese firm has entered the European regulatory process and Novo Nordisk has bought rights to ...
Pope Leo had a lower lobe of his right lung removed on Tuesday and was diagnosed with lung adenocarcinoma, a common form of lung cancer, the Vatican said in a medical bulletin. Leo, 71, was admitted ...
TRACE-I: Long-Term Outcomes of PSMA-Guided Salvage Surgery in Recurrent Prostate Cancer / cancer, cancer care, Cancer ...
Small Cap Watch: Orthocell reports promising prostate surgery recovery data as Pilbara Gold extends high-grade discovery Proactive uses images sourced from Shutterstock The S&P/ASX Small Ordinaries ...
Despite its due late-stage stem cell trial failures, Cynata is passing the hat for just over $900,000 in an underwritten rights offer ...
Final 2025 CDC data show a record-low U.S. fertility rate of 53.2 and a 7% drop in teen births. What the numbers mean for maternity care access. Ric Flair Hospitalized Following Tampa Fall Hours After ...